文 | 独角金融 刘银平 编辑 | 付影 百年人寿又一家分支机构被罚。 9月1日，根据龙岩金融监管分局公开的行政处罚信息，百年人寿龙岩中心支公司因财务数据不真实、虚 构保险中介业务套取费用被罚款20.5万元，时任龙岩中支银行保险室负责人蒋占臣槟、龙岩中支个险营 销培训室主任赖福秀被警告并分别罚款2万元。 近一年百年人寿各地分支机构因违法违规行为已经被监管处罚7次，平均不到两个月就有一家分支机构 被罚，2024年以来罚款金额累计超200万元。 前不久据"财新"报道，百年人寿创业元老及原总裁等人被查，再次暴露了公司内部治理失效，此前已有 3名主要高层"落马"。 自2023年1季度以来，百年人寿就未再披露偿付能力报告，根据其5月披露的重大关联交易公告，关联交 易金额281亿元，大量流向地产股东，且84亿元资金尚未追回。 2024年国资进场成第一大股东，万达集团退居第二大股东，董事会也大"换血"，新的领导班子能否带领 百年人寿走出困境？ 1、不到2年，分支机构累计被罚220万元 近两年，百年人寿各地分支机构被采取监管措施次数较多，近一年已经收到7张罚单，累计罚款金额 103.9万元。 7月18日，百年人寿延边中心支公 ...

Group 1 - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Suwu, stock code: 600200) has been investigated by the China Securities Regulatory Commission (CSRC), which may lead to a forced delisting if major violations are confirmed [1] - The company faces financial delisting risks due to its 2024 financial report receiving a disclaimer of opinion from the auditing firm, triggering delisting risk warnings from the Shanghai Stock Exchange [2] - The company's financial situation is deteriorating, with declining revenue and profits, and increasing debt pressure, indicating serious financial distress [2] Group 2 - A significant issue arose when the chairman of the company's wholly-owned subsidiary was criminally charged for fraudulently obtaining export tax rebates, highlighting internal management and compliance failures [2] - This criminal case could severely damage the company's reputation and creditworthiness, impacting its business expansion and financing capabilities [2] - Investors who purchased shares before February 26, 2025, and sold or still hold them as of February 27, 2025, may be eligible for compensation, pending court validation [3]